News

ELITechGroup

Filter

Open filter menu
Reset
Reset

Test video

https://dev.elitechgroup.com/news/wp-content/uploads/sites/33/2023/05/Eliver-Teaser-1.1-1-11.mp4 this is a test video

ELITechGroup Molecular inaugurates its new headquarter in Turin

Turin, 22nd December 2022 – ELITechGroup has inaugurated its new headquarters in Turin, becoming one of the largest molecular biology hubs in Europe. The inauguration was held on Friday 16th December in the presence of institutional figures, collaborators, and employees. At the ribbon cutting, Michela Favaro – Deputy Mayor of…

ELITe InGenius™ nominated for Scientists’ Choice Awards®!

  ELITe InGenius™ nominated for Scientists’ Choice Awards! Each year the Scientists’ Choice Awards® celebrates the laboratory products and manufacturers that make a difference to the industry. SelectScience began the Scientists’ Choice Awards® in 2007 to enable scientists to voice their opinions on the best laboratory products. Scientists are then…

ELITechGroup receives CE mark

ITALY, Torino, December 9th, 2021. ELITechGroup announced today that its SARS-CoV-2 Extended ELITe MGB® Kit reliably differentiates the SARS-CoV-2 Omicron (B.1.1.529) variant from other variants of concern. The in-silico analysis was confirmed by testing patient samples positive for different SARS-CoV-2 variants including Omicron. ELITechGroup is pleased to offer the SARS-CoV-2…

Our new Molecular MDR/MTB multiplex assay

Een high performance based on our MGB® technology: – MTB complex: M.tuberculosis, M.africanum, M.bovis, M.canetti, M.microti, M.caprae. – MGB resistence: Rifampicine en Izoniazide. – Ultra sensitive: 6CFU/ml! – Ready to use monoreagent. In combination with our RT-PCR Sample-to-Result ELITe InGenius the most flexible solution for the diagnosis of Tuberculosis. “

ELITechGroup soutient AIDES & La ligue contre le cancer

Puteaux, France, le 15 Avril 2022, (14h CEST) ELITechGroup, fabricant et distributeur d’équipements et de réactifs de diagnostic in vitro, a annoncé apporter son soutien en offrant une aide financière auprès de deux associations françaises : AIDES et La Ligue contre le canc ELITechGroup, acteur incontournable de la biologie moléculaire,…

ELITechGroup supports AIDES & La Ligue contre le cancer

Puteaux, France, April 28th, 2022 – ELITechGroup, manufacturer and distributor of in vitro diagnostic instruments and reagents, has announced its charitable contributions to two French associations: AIDES and La Ligue contre le cancer. ELITechGroup, a key player in molecular biology diagnostics and clinical chemistry, brings together the expertise of innovative…

ELITechGroup’s donation to support Ukraine

Turin, 5th April, 2022 – ELITechGroup donated € 30,000 to provide emergency aid to Ukraine in response to the humanitarian crisis. Given the dramatic situation in Ukraine, ELITechGroup took immediate action to collaborate with SERMIG, a non-profit organisation based in Turin, Italy, with more than 50 years of experience in…

ELITechGroup celebrates the installation of the 1000th ELITe InGenius® system

Turin, 23rd December, 2021 – It is with great satisfaction that ELITechGroup announces the installation of the 1000th ELITe InGenius® system. This milestone – achieved only 5 years after the launch of the product – clearly demonstrates the worldwide success of the company’s fully automated sample-to-result Real Time PCR platform.…

A PCR kit that differentiates the SARS-CoV-2 Omicron Variant

Bothell, WA December 10, 2021 ELITechGroup MDx LLC (“ELITechGroup MDx”) announced today that its Research Use Only (RUO) SARS-CoV-2 Extended test kit reliably differentiates the SARS-CoV-2 Omicron (B.1.1.529) variant from other variants of concern. The in-silico analysis was confirmed by testing patient samples positive for different SARS-CoV-2 variants including Omicron.…

The first PCR kit that differentiates the SARS-CoV-2 Omicron Variant

ITALY, Torino, December 9th, 2021. ELITechGroup announced today that its SARS-CoV-2 Extended ELITe MGB® Kit reliably differentiates the SARS-CoV-2 Omicron (B.1.1.529) variant from other variants of concern. The in-silico analysis was confirmed by testing patient samples positive for different SARS-CoV-2 variants including Omicron. ELITechGroup is pleased to offer the SARS-CoV-2…

ELITechGroup announces the launch of ELITe BeGenius®

ITALY, Torino, October 12th, 2021. It is with great satisfaction that ELITechGroup announces the launch of ELITe BeGenius®, the new CE-IVD stand-alone “Sample – to – Result” Real Time PCR solution. ELITe BeGenius® makes molecular biology universally accessible thanks to its compact footprint, exceptional ease-of-use, and total automation. Tailorable for…